HLN logo

Haleon plc American Depositary Shares (Each representing two) (HLN)

$10.07

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HLN

Market cap

$44.43B

EPS

0.16

P/E ratio

20.4

Price to sales

2.94

Dividend yield

1.275%

Beta

0.117868

Price on HLN

Previous close

$10.03

Today's open

$10.15

Day's range

$10.05 - $10.20

52 week range

$8.65 - $11.28

Profile about HLN

CEO

Brian McNamara

Employees

24000

Headquarters

Weybridge, Surrey

Exchange

New York Stock Exchange

Shares outstanding

4.45B

Issue type

American Depository Receipt

HLN industries and sectors

Healthcare

Pharmaceuticals

News on HLN

17 Ideal 'Safer' Buyable August Dogs Dug Up After 10 Years

I analyze 89 top Ten-Year Collected Dividend Dogs, focusing on yield-based strategies and safety via free cash flow coverage. Ten-year top dividend dogs project average net gains of 39.61% by August 2027, with risk profiles generally below market volatility. Seventeen 'safer' dogs meet the ideal of annual dividends from $1K invested exceeding share price, signaling strong income potential.

news source

Seeking Alpha • Aug 28, 2026

news preview

LCUT vs. HLN: Which Stock Is the Better Value Option?

Investors interested in Consumer Products - Discretionary stocks are likely familiar with Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks presents investors with the better value opportunity right now?

news source

Zacks Investment Research • Aug 26, 2026

news preview

Jefferies raises Haleon price target to 410p on margin strength

Jefferies has raised its price target for Haleon (Haleon PLC (LSE:HLN, NYSE:HLN), the consumer health company behind Sensodyne and Advil, to 410p from 400p, maintaining its Buy rating. The broker highlighted a 70 basis point margin beat in the first half of the year, though it warned this revived concerns about whether Haleon was investing enough behind growth.

news source

Proactive Investors • Aug 24, 2026

news preview

Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes

LONDON, Aug. 19, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces the pricing terms, expiration and results of the offer to buy back any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 (the "Notes") of Haleon US Capital LLC's (the "Offeror"), the Company's wholly owned subsidiary (the "Tender Offer"). The Tender Offer has been made upon the terms and subject to the conditions set forth in the Offer to Purchase dated 11 August 2026 (the "Offer to Purchase").

news source

PRNewsWire • Aug 19, 2026

news preview

Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes

LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. Bondholders will receive a price equal to the Total Consideration based on the Reference Yield and the Fixed Spread plus Accrued Interest (each as defined below) (the "Tender Offer").

news source

PRNewsWire • Aug 11, 2026

news preview

Haleon plc (HLN) Q2 2026 Earnings Call Prepared Remarks Transcript

Haleon plc (HLN) Q2 2026 Earnings Call Prepared Remarks Transcript

news source

Seeking Alpha • Aug 5, 2026

news preview

ACCO vs. HLN: Which Stock Is the Better Value Option?

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Acco Brands (ACCO) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the best option for those looking for undervalued stocks?

news source

Zacks Investment Research • Aug 4, 2026

news preview

Haleon slides as quality of growth questioned

Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 2.9% to 368.7p after the consumer healthcare group reported improving second-quarter sales but left its full-year guidance unchanged. Organic revenue increased 3.1% in the second quarter, split between 1.7% from pricing and 1.4% from volumes and product mix.

news source

Proactive Investors • Jul 30, 2026

news preview

Haleon plc (HLN) Q2 2026 Earnings Call Transcript

Haleon plc (HLN) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Jul 30, 2026

news preview

Sensodyne maker Haleon posts higher second-quarter organic revenue growth

British consumer ​health company Haleon ‌reported second-quarter organic ​sales ​growth of 3.1% ⁠on ​Thursday, in ​line with market expectations, driven ​by ​strong demand for ‌its ⁠oral health products and accelerating ​growth ​in ⁠North America, ​its largest ​market.

news source

Reuters • Jul 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Haleon plc American Depositary Shares (Each representing two)

Open an M1 investment account to buy and sell Haleon plc American Depositary Shares (Each representing two) commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HLN on M1